Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Congestive Heart Failure
Interventions
OTHER

Drug therapy for HF

Titration of HF meds in an aggressive out patient manner following guideline direction

OTHER

NT-proBNP guided HF therapy

Standard of care drug therapy following guideline direction, plus adjustment of medication titrated to achieve NT-proBNP \<1000 pg/mL

Trial Locations (1)

02467

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00351390 - Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting. | Biotech Hunter | Biotech Hunter